Ma G, Deng Y, Qian L, Vallega KA, et al. Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both. Oncogene 2022;41:1691-1700.
PMID: 35102249